Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

Clinical trial NCT06580106 · RECRUITING

Trial details

NCT number: NCT06580106
Sponsor: Wake Forest University Health Sciences
Status: RECRUITING
Study type: OBSERVATIONAL

Leukemia, Myeloid, Acute

Start date: 2025-04-09
Primary completion: 2027-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.